Anti-mullerian Hormone Levels in Healthy Females

Part of paid clinical trials in Chicago, Illinois.

Sponsor
Erin Rowell
Study ID
NCT04537390
Status
Recruiting
Apply to this trial

Conditions

  • Healthy

Eligibility Criteria

Sex
FEMALE
Age
N/A - 18 Years
Healthy Volunteers
Accepted

Interventions

  • Blood sample collection — DIAGNOSTIC_TEST
    Blood samples are collected for diagnostically assessing how the blood AMH levels correspond to a female's reproductive development

Study Details

The purpose of this study is to have a better understanding of the normal blood levels of AMH in females from 0-18 years of age and how the blood AMH levels correspond to a female's reproductive development.

Key Dates

Start date
Jul 19, 2016
Status verified
Nov 2024
Primary completion
Dec 1, 2030
Completion
Dec 1, 2030

Study Design

Enrollment
100 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC

Arms

  • Other: Blood sample collection
    Blood samples are collected for diagnostically assessing how the blood AMH levels correspond to a female's reproductive development

Primary Outcome Measure

Anti-mullerian Hormone Levels in Healthy Females [ Time Frame: 3 Years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Ann & Robert H Lurie Children's Hospital of ChicagoChicagoIllinois60611
Jacquelyn Searcy
[email protected]
3122274758
Erin Rowell, MD

Find similar trials in Chicago, IL

By research site
Ann & Robert H Lurie Children's Hospital of Chicago· Chicago, IL

Related Studies